Signal Proxy Intelligence
For Immediate Release

New York, NY – 2026-07-24 · Ticker: NASDAQ:VSEE

Signal Proxy Intelligence Recommends AGAINST on The Reverse Stock Split Proposal at VSEE HEALTH, INC. Ahead of Aug. 25, 2026 Annual Meeting

Independent research firm publishes item-by-item recommendations on all four ballot measures within 4 days of the company’s proxy filing. (Exceeds SPI’s standing 48-hour / T+2 commitment; the time stated above is the actual elapsed time to publication.)

NEW YORK, NY — Signal Proxy Intelligence, the independent proxy research division of Signal Law Group, today published its recommendations for the Aug. 25, 2026 annual meeting of VSEE HEALTH, INC. (NASDAQ:VSEE). SPI issued a recommendation on each of the four items on the ballot, published 4 days after the company’s definitive proxy statement was accepted on EDGAR.

Reviewing the ballot from the perspective of the common shareholder and using publicly available information only, SPI assigned the meeting a concern band of Elevated. The firm recommends AGAINST on the Reverse Stock Split Proposal, citing that filing states the reverse stock split could discourage takeover attempts and limit stockholders’ opportunity to sell at higher prices.

On the election of directors, SPI recommends FOR the director nominees as presented on the ballot.

“This ballot included one item where our recommendation diverged from the board’s under our published framework. The meeting carries a concern band of Elevated, and the full rationale for each recommendation is documented in the report.”

Hayden Smith, Head of Proxy Research

SPI recommends AGAINST on the following item:

  • AGAINST on Item 3 (The Reverse Stock Split Proposal): Filing states the reverse stock split could discourage takeover attempts and limit stockholders’ opportunity to sell at higher prices.

SPI will publish a separate post-meeting divergence report comparing its recommendations to those of the incumbent proxy advisors after the meeting results are available.

The complete item-by-item analysis, including the rationale for each recommendation, is available at https://www.signallawgroup.com/proxies/vsee-health-inc-2026-08-25/.

Class: Common Stock or Series A Preferred Stock, par value $0.0001 per shareCUSIP: 92919Y102Record Date: July 6, 2026Meeting Date: Aug. 25, 2026

Ballot Summary: Recommendation by Item

Item Title SPI Recommendation
1 The Directors Proposal FOR
2 The Auditor Proposal FOR
3 The Reverse Stock Split Proposal AGAINST
4 The Adjournment Proposal FOR

About Signal Proxy Intelligence

SPI is the independent proxy research division of Signal Law Group, an independent research and investigations firm. SPI publishes FOR / AGAINST / WITHHOLD recommendations on every item of every covered proxy ballot within 48 hours of filing, analyzing each measure from the perspective of the common shareholder using publicly available information. SPI accepts no revenue from the companies it covers. Every SPI recommendation is timestamped at publication, fingerprinted, and reconciled against the company’s reported vote.

Media contact

Rochelle Welner
contact@signallawgroup.com

Publication timestamp: 2026-07-24 07:37:37 ETDraft content fingerprint (SHA-256): e62fa665f664ae239a822abe24ab2291e17cfcbea123a0214c2b44e5d2dc30b8

# # #


SPI is an operating company of Signal Law Group, an independent research and investigations firm. SPI is not a law firm, does not provide legal advice, and is not an investment adviser. The recommendations and analysis in this release are independent research provided for informational purposes only. They do not constitute voting advice, investment advice, a recommendation to buy or sell securities, or a solicitation of any kind. Recipients should conduct their own independent analysis and consult their own advisors before making any voting or investment decision. SPI accepts no revenue from the companies it covers.

About The Author